DENTSPLY SIRONA Business Summary

Dentsply Sirona Inc. operates as a global leader in the design and manufacture of professional dental products and technologies, generating revenue through a diversified portfolio of consumables, equipment, and digital clinical solutions. Its business model is organized into four core segments: Connected Technology Solutions (CTS), which focuses on CAD/CAM and imaging; Essential Dental Solutions (EDS), covering restorative and endodontic consumables; Orthodontic and Implant Solutions (OIS); and Wellspect Healthcare, specializing in continence care. The company employs a "connected dentistry" strategy, integrating hardware with cloud-based software like DS Core to drive clinical efficiency and recurring service value. Key direct competitors include Envista Holdings, Align Technology, the Straumann Group, and Henry Schein. While Align and Straumann lead in specialized niches like clear aligners and premium implants, Dentsply Sirona maintains a unique market position as the most comprehensive end-to-end provider of both clinical supplies and integrated digital equipment. The company’s leadership is spearheaded by President and CEO Daniel Scavilla, who assumed the role in August 2025 following a successful tenure as CEO of Globus Medical and 28 years at Johnson & Johnson. He is supported by EVP and CFO Matthew E. Garth, formerly of Diebold Nixdorf, and SVP and CTO Kevin Boyle, a MedTech veteran with deep R&D experience from Becton Dickinson and Medtronic. The Board of Directors, chaired by Gregory T. Lucier, was expanded in February 2026 with the appointments of veteran healthcare banker James D. Forbes and former IDEXX CFO Brian P. McKeon to oversee the company’s "Return-to-Growth" action plan. Major institutional backing from firms like The Vanguard Group and BlackRock underscores the company's status as a foundational asset in the dental healthcare sector, as management pivots toward debt reduction and aggressive R&D reinvestment following the 2026 elimination of its common stock dividend.